Skip to main content
Equibles

FIRST MANHATTAN CO. LLC.

Position in ROIV — Roivant Sciences Ltd.

CIK 728083 NEW YORK, NY
Back to ROIV Full portfolio

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$394,456
+$85,712 QoQ
Shares Held
11,146
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST MANHATTAN CO. LLC. holds $1,927,732 across 8 Biotechnology names. ROIV ranks #2 (20.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,560 $774,898
2 ROIV
Roivant Sciences Ltd.
This page 		11,146 $394,456
3 TSHA
Taysha Gene Therapies, Inc.
 43,500 $296,235
4 IMRX
Immuneering Corp
 24,245 $120,982
5 IOVA
Iovance Biotherapeutics, Inc.
 27,998 $116,471
6 IBRX
ImmunityBio, Inc.
 10,000 $87,550
7 OVID
Ovid Therapeutics Inc.
 26,000 $69,940
8 ABUS
Arbutus Biopharma Corp
 14,000 $67,200

All Filings in ROIV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $394,456 11,146
2026-03-31 $308,744 11,146
2025-12-31 $241,868 11,146
2025-09-30 $183,073 12,100
2025-06-30 $136,367 12,100
2025-03-31 $122,089 12,100
2024-12-31 $143,143 12,100
2024-09-30 $137,326 11,900
2024-06-30 $120,498 11,400
2024-03-31 $120,156 11,400
2023-12-31 $123,530 11,000
2023-09-30 $128,480 11,000
2023-06-30 $110,880 11,000
2023-03-31 $81,180 11,000